SELVA study principal investigator and Stanford University Dermatology and Pediatrics professor Joyce Teng said: “Patients with microcystic LMs often have lymphorrhoea, bleeding, infection ...

Palvella's expansion of the SELVA clinical trial to include patients aged 3 to 5 years old demonstrates a commitment to addressing the needs of younger patients suffering from microcystic LMs ...

The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, established new approaches to both CNS tumor nomenclature and grading, emphasizing the ...

Presence of microcystic macular oedema (MMO) was determined visually as described.26 The macular ganglion cell layer and inner plexiform layer were segmented. Compound mGCIPL thickness was calculated.